Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Severe bronchiectasis.

Brian M Morrissey1, Samuel J Evans

  • 1Division of Pulmonary/Critical Care Medicine, University of California, Davis School of Medicine, Davis, CA, USA. bmmorrissey@ucdavis.edu

Clinical Reviews in Allergy & Immunology
|January 13, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

α-Tocopherol Pharmacokinetics in Adults with Cystic Fibrosis: Benefits of Supplemental Vitamin C Administration.

Nutrients·2022
Same author

The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.

Expert review of clinical pharmacology·2022
Same author

Quantitative assessment of cyanide in cystic fibrosis sputum and its oxidative catabolism by hypochlorous acid.

Free radical biology & medicine·2018
Same author

Safety and Clinical Utility of Flexible Bronchoscopic Cryoextraction in Patients With Non-neoplasm Tracheobronchial Obstruction: A Retrospective Chart Review.

Journal of bronchology & interventional pulmonology·2015
Same author

Acute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapies.

Journal of thoracic disease·2015
Same author

Inflammation, oxidative stress, and cardiovascular disease risk factors in adults with cystic fibrosis.

Free radical biology & medicine·2014
Same journal

Therapeutic Targeting of the Bradykinin B2 Receptor in Immunological and Vascular Diseases: Insights from Kinin Biology to Clinical Outcomes.

Clinical reviews in allergy & immunology·2026
Same journal

β-blocker Therapy in Cholinergic Urticaria, Adrenergic Urticaria and the Aquagenic Continuum Beta-Blocker Therapy in Chronic Inducible Urticaria.

Clinical reviews in allergy & immunology·2026
Same journal

Immunopathogenesis and Cytokine Pathways in Reactive Infectious Mucocutaneous Eruption (RIME) in Pediatric Population: Infectious Triggers and Molecular Insights.

Clinical reviews in allergy & immunology·2026
Same journal

Neuropsychological Factors in Vitiligo: Mechanisms and Clinical Application.

Clinical reviews in allergy & immunology·2026
Same journal

Tertiary Lymphoid Structure: A Potential Therapeutic Target Affecting Immune Response in Autoimmune Diseases.

Clinical reviews in allergy & immunology·2026
Same journal

Differentiating Acute-onset Autoimmune Hepatitis From Drug-Induced Autoimmune-like Hepatitis: A Multicenter Study and Score Development.

Clinical reviews in allergy & immunology·2026
See all related articles

Bronchiectasis, a lung disease from chronic inflammation and infection, requires early diagnosis for chronic cough and sputum. Prompt treatment prevents irreversible lung function loss.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Immunology

Background:

  • Bronchiectasis stems from airway injury and remodeling due to chronic inflammation and infection.
  • Causes include autoimmune diseases, severe infections, genetic factors, and acquired conditions like allergic bronchopulmonary mycoses or HIV/AIDS.
  • It presents with chronic cough and sputum, potentially leading to airway sepsis and acute exacerbations.

Purpose of the Study:

  • To review the pathophysiology, clinical presentations, and management of severe non-cystic fibrosis bronchiectasis.
  • To highlight the vicious cycle of impaired airway clearance, unresolved infection, and recurrent injury.
  • To discuss common pathogens and therapeutic strategies.

Main Methods:

  • Review of current literature on bronchiectasis pathophysiology, clinical features, and management.

Related Experiment Videos

  • Presentation of common clinical manifestations and radiographic findings.
  • Discussion of microbial organisms and treatment modalities.

    • Main Results:

    • Bronchiectasis involves a cycle of impaired airway clearance, infection, and inflammation.
    • Common pathogens include Mycobacterium species, Aspergillus, and Pseudomonas aeruginosa.
    • Management includes sputum surveillance, clearance, antimicrobial therapy, and anti-inflammatory agents.

    Conclusions:

    • Early recognition and treatment of bronchiectasis are crucial to prevent disease progression.
    • Effective management involves addressing underlying causes, clearing airways, and treating infections.
    • Therapeutic options include antimicrobials, antifungals, and anti-inflammatory drugs for severe cases.